local
Sickle cell gene therapy helps man overcome disease after 20 years
Summary by The Midland Editorial Desk LeAnne Gendreau , as published by KOSA CBS7 / First Alert 7 (Permian Basin CBS)
· August 10, 2026
· 1 min read
Photo: KOSA CBS7 / First Alert 7 (Permian Basin CBS) · view original
Story provenance No corrections
Summary created by The Midland Editorial Desk — automated, rule-governed Byline on source page LeAnne Gendreau, as published by KOSA CBS7 / First Alert 7 (Permian Basin CBS) Original story Read at the source Source published Aug 10, 2026 Indexed here Aug 10, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log
Key takeaway The therapy was approved by the Food and Drug Administration in late 2023, and its effects on the patient's condition have been reported.
A new treatment has shown promise for individuals with sickle cell anemia. This condition affects the shape of red blood cells, leading to severe pain and complications. A specific gene therapy has been used to help a patient overcome the disease.
Further details about this treatment are available from the source. The patient, a 20-year-old man, underwent this therapy and experienced significant improvement. The therapy was approved by the Food and Drug Administration in late 2023, and its effects on the patient's condition have been reported.
Why this matters
Local news anchors readers in their community — the people, places, and decisions that shape day-to-day life. The Midland covers these stories because national outlets often won't.
About this story
As published by KOSA CBS7 / First Alert 7 (Permian Basin CBS) . The Midland surfaces reporting from trusted publishers and adds local editorial context so readers can quickly understand what a story means for their community. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit KOSA CBS7 / First Alert 7 (Permian Basin CBS) . Have a tip or correction? Contact our newsroom .
Category: local Published: August 10, 2026 Source: KOSA CBS7 / First Alert 7 (Permian Basin CBS) Reading time: 1 min
Frequently asked about this story
What is this story about? A new treatment has shown promise for individuals with sickle cell anemia. This condition affects the shape of red blood cells, leading to severe pain and complications. A specific gene therapy has…
When was this published? This article was first published on August 10, 2026 by KOSA CBS7 / First Alert 7 (Permian Basin CBS) and curated for The Midland readers.
Who reported this story? This story was reported by LeAnne Gendreau at KOSA CBS7 / First Alert 7 (Permian Basin CBS). To learn more about how The Midland selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more local coverage from The Midland, or browse our daily briefing and topic hubs .
← Back to all news
More local →
Today’s briefing
Subscribe to newsletter
